Showing results (11-20 of 111) with videos related to
Sort By:
Pageof 12
Drug Safety|December 23, 2020
Developing Crowdsourced Training Data Sets for Pharmacovigilance Intelligent AutomationAlex Gartland, Andrew Bate, Jeffery L Painter, et al.Plos One|February 16, 2023
Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosusJoel N Swerdel, Darmendra Ramcharran, Jill HardinMaternal and Child Health Journal|June 24, 2005
Economic impact on families caring for children with special health care needs in New Hampshire: the effect of socioeconomic and health-related factorsJudith Bumbalo, Lee Ustinich, Darmendra Ramcharran, et al.Journal of Clinical Psychopharmacology|February 23, 2017
Atypical Antipsychotics and the Risk of Falls and Fractures Among Older Adults: An Emulation Analysis and an Evaluation of Additional Confounding Control StrategiesDarmendra Ramcharran, Hong Qiu, Martijn J Schuemie, et al.Drugs & Aging|January 27, 2017
Atypical Antipsychotics and the Risks of Acute Kidney Injury and Related Outcomes Among Older Adults: A Replication Analysis and an Evaluation of Adapted Confounding Control StrategiesPatrick B Ryan, Martijn J Schuemie, Darmendra Ramcharran, et al.Advances in Experimental Medicine and Biology|September 25, 2010
Toward automating an inference model on unstructured terminologies: OXMIS case studyJeffery L PainterThe Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 22, 2006
High caffeine intake in adolescents: associations with difficulty sleeping and feeling tired in the morningRebecca L Orbeta, Mary D Overpeck, Darmendra Ramcharran, et al.Journal of Psychosomatic Research|October 18, 2011
Social support and clinical outcomes during antiviral therapy for chronic hepatitis CDonna M Evon, Denise A Esserman, Darmendra Ramcharran, et al.The American Journal of Gastroenterology|October 1, 2009
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C studyDonna M Evon, Darmendra Ramcharran, Steven H Belle, et al.Drug Safety|May 17, 2022
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping ReviewBenjamin Kompa, Joe B Hakim, Anil Palepu, et al.Pageof 12